dc.contributor | Galavíz Hernández, Carlos | |
dc.creator | WALLANDER COMPEÁN, LILIANA | |
dc.date.accessioned | 2013-05-08T21:29:34Z | |
dc.date.available | 2013-05-08T21:29:34Z | |
dc.date.created | 2013-05-08T21:29:34Z | |
dc.date.issued | 2011-06-14 | |
dc.identifier | http://www.repositoriodigital.ipn.mx/handle/123456789/15633 | |
dc.description.abstract | CYP450 genes are highly polymorphic, which determines the synthesis of enzymes with low, increased or null activity. CYP2C enzymes are well known for their ability to metabolize more than 20% of available drugs. CYP2C sub-family include three genes CYP2C8, CYP2C9 and CYP2C19, the latter engaged to metabolize 2% of all drugs. There exist a great inter-ethnic variability in the frequency of allelic variants CYP2C19, *2, *3 and *4, which are associated with a higher prevalence of poor metabolizer phenotype. Methods: Real time PCR was used to determine the polymorphic variants *2, *3 and *4 in CYP2C19 gene in 150 subjects from different indigenous communities (Huicholes, Coras and Tepehuanos) from Durango and Nayarit states. Results: CYP2C19*2 allele was found with a frequency of 0.09 (9%) in Huicholes, 0.08 (8%) in Coras and 0.1 (10%) in Tepehuanos. CYP2C19*3 and *4 were not found in the studied populations. Conclusions: The results found in this study on indigenous populations from Durango and Nayarit, provides valuable information about the frequency of CYP2C19 *2 polymorphism which could be important to determine guidelines on drug treatment in these populations. | |
dc.language | es | |
dc.subject | población Indígena | |
dc.subject | polimorfismos del CYP2C19 | |
dc.subject | farmacología | |
dc.title | Frecuencias alélicas y genotípicas de los polimorfismos *2, *3 y *4 del gen CYP2C19 en poblaciones de origen Huichol, Cora y Tepehuana de Nayarit y Durango | |
dc.type | Thesis | |